Back to Search Start Over

Suspected inappropriate use of prescription and non-prescription drugs among requesting customers: A Saudi community pharmacists’ perspective

Authors :
Ayesha Yasmeen
Mamoon H. Syed
Saad S. Alqahtani
Nabeel Kashan Syed
Abdulkarim M. Meraya
Mayyada Wazaify
Marie-Claire Van Hout
Source :
Saudi Pharmaceutical Journal, Vol 31, Iss 7, Pp 1254-1264 (2023)
Publication Year :
2023
Publisher :
Elsevier, 2023.

Abstract

Background: Inappropriate use of medications is a global health concern, and this is attributed to the increased accessibility to prescription and non-prescription (over-the-counter) drugs at community pharmacies. We investigated the inappropriate use of prescription and non-prescription drugs in community pharmacies based on the perspectives of the community pharmacists in Saudi Arabia. Methods: This was a questionnaire-based, cross-sectional survey which employed convenient sampling (snowball technique) to recruit participants. Being a licensed practicing pharmacist in a retail chain or an independent community pharmacy was the inclusion criteria. Participants were asked to report the drugs they suspected of being inappropriately used along with the frequency, age and gender of the suspected customers. Pharmacists were also asked to mention the action taken to limit inappropriate use at their pharmacy. Results: A total of 397 community pharmacists completed the questionnaire (86.9 % response rate). 86.4% of the pharmacists suspected some level of abuse or misuse to have occurred. After receiving the questionnaire, the pharmacists reported suspected inappropriate use as encountered during the past three months. Cumulative inappropriate use was reported 1069 times (prescription drugs – 530; non-prescription drugs – 539). The top three inappropriately used prescription-drug categories were gabapentinoids (22.5%), antipsychotics (17.5%) and topical corticosteroids (12.1%). Among non-prescription drugs, cough products (33.2%) ranked first, followed by cold and flu products (29.5%) and first-generation antihistamines (10.8%). The cross tabulations revealed that being in the age range of 26–50 years and being a male was significantly associated (p

Details

Language :
English
ISSN :
13190164
Volume :
31
Issue :
7
Database :
Directory of Open Access Journals
Journal :
Saudi Pharmaceutical Journal
Publication Type :
Academic Journal
Accession number :
edsdoj.31d92ee320ed4403b8cfeab68d7a6d81
Document Type :
article
Full Text :
https://doi.org/10.1016/j.jsps.2023.05.009